TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.

Bazile C, Abdel Malik MM, Ackeifi C, Anderson RL, Beck RW, Donath MY, Dutta S, Hedrick JA, Karpen SR, Kay TWH, Marder T, Marinac M, McVean J, Meyer R, Pettus J, Quattrin T, Verstegen RHJ, Vieth JA, Latres E

Open source

DOI: 10.3389/fimmu.2024.1470677
Published: 2024
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1470677,
  title = {TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.},
  author = {Bazile C and Abdel Malik MM and Ackeifi C and Anderson RL and Beck RW and Donath MY and Dutta S and Hedrick JA and Karpen SR and Kay TWH and Marder T and Marinac M and McVean J and Meyer R and Pettus J and Quattrin T and Verstegen RHJ and Vieth JA and Latres E},
  year = {2024},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2024.1470677},
  url = {https://doi.org/10.3389/fimmu.2024.1470677}
}

RIS

TY  - JOUR
TI  - TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.
AU  - Bazile C
AU  - Abdel Malik MM
AU  - Ackeifi C
AU  - Anderson RL
AU  - Beck RW
AU  - Donath MY
AU  - Dutta S
AU  - Hedrick JA
AU  - Karpen SR
AU  - Kay TWH
AU  - Marder T
AU  - Marinac M
AU  - McVean J
AU  - Meyer R
AU  - Pettus J
AU  - Quattrin T
AU  - Verstegen RHJ
AU  - Vieth JA
AU  - Latres E
PY  - 2024
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2024.1470677
UR  - https://doi.org/10.3389/fimmu.2024.1470677
ER  -

APA

C, B., MM, A. M., C, A., RL, A., RW, B., MY, D., S, D., JA, H., SR, K., TWH, K., T, M., M, M., J, M., R, M., J, P., T, Q., RHJ, V., JA, V., & E, L. (2024). TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2024.1470677

Source records

pubmed · retrieved 2026-09-25T11:49:04.966Z